semaglutide and retatrutide vs Semaglutide: Speed of Weight Loss Comparison Acute and chronic effects of

Note that outcomes are variable

Cell 165(1):180191

Existing kidney problems, and being older, both raise the stakes on fluid loss

Sim, M

Exp Neurobiol 25:113 Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis

Why this matters (and dont underestimate it): ~20% weight loss in non-diabetic obesity (REDEFINE-1) 1416% weight loss in T2D (REDEFINE-2) Dual mechanism = appetite suppression + satiety reinforcement Designed for long-term maintenance, not just short-term loss Potentially better GI tolerability with flexible titration This isnt another GLP-1. Its a clear signal that amylin is emerging as a serious second pillar in next-gen obesity care